Extrafine single-inhaler triple therapy with BDP/FF/GB is effective for improving health-related quality of life and lung function in COPD.

Marcus McDonald, an Emmy Silver Circle award-winning photojournalist, shares how he overcame lung cancer.

Avalyn Pharma's IPO aims to fund inhaled IPF therapies as AP01 shows positive Phase II results. Read the full analysis here.

In patients with post- and precapillary pulmonary hypertension and heart failure with preserved ejection fraction, ...

A recent study shows links between pulmonary alterations in diabetes and whole-body insulin sensitivity and insulin clearance, which may represent underlying mechanisms.

Select your location to view local American Lung Association events and news near you.

Severe respiratory viral infection increases risk for lung cancer, according to study results.The findings — derived from work in murine models and retrospective analyses of data from humans — ...

In a systematic review and meta-analysis, researchers found that occupational exposure to talc that is not contaminated with ...

AllRock Bio, Inc., a clinical-stage biotechnology company focused on advancing impactful therapies for cardiopulmonary and ...

According to the latest market analysis by Future Market Insights, the global lung cancer surgery market is entering a phase ...

Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences ...

Nuvalent seeks FDA approval of neladalkib for TKI-pretreated advanced ALK-positive NSCLC, leveraging ALKOVE-1 results demonstrating activity in extracranial disease and brain metastases. ALKOVE-1 ...